Russell P. Elliott, VP Drug Development at Foamix Pharmaceuticals Ltd. (FOMX), sold 817 shares at $6.14 ($5K) on 2018-03-02, disclosed to the SEC on 2018-03-06.
Open-market sale of $5k FOMX by VP Drug Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FOMX | SELL | 2018-04-04 | $721 | — | Filing → |